Myriad Genetics Inc (NASDAQ:MYGN)

33.14
Delayed Data
As of Feb 23
 +0.44 / +1.35%
Today’s Change
17.50
Today|||52-Week Range
41.57
-3.51%
Year-to-Date

Today’s Trading

Previous close32.70
Today’s open32.82
Day’s range32.13 - 33.25
Volume392,166
Average volume (3 months)849,512
Market cap$2.3B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)+9.52%
Earnings growth (next 5 years)+9.30%
Revenue growth (last year)+2.33%
P/E ratio18.0
Price/Sales2.30
Price/Book2.91

Competitors

----
NEOGNeogen Corp+0.62+1.04%
IMMUImmunomedics Inc+0.64+3.91%
QDELQuidel Corp+0.23+0.53%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.26
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts